| 产品编号 | CFN60035 | |
| CAS编号 | 49843-98-3 | |
| 分子式 = 分子量 | C13H13ClN2O = 248.71 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| Selisistat | CFN60035 | 49843-98-3 | 1mg | QQ客服:2159513211 |
| Selisistat | CFN60035 | 49843-98-3 | 5mg | QQ客服:2159513211 |
| Selisistat | CFN60035 | 49843-98-3 | 10mg | QQ客服:2159513211 |
| Selisistat | CFN60035 | 49843-98-3 | 20mg | QQ客服:2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Selisistat (EX 527, SEN0014196) is a potent and selective SIRT1 inhibitor with IC50 of 38 nM in a cell-free assay, exhibits >200-fold selectivity against SIRT2 and SIRT3. | |||
| Targets: | SIRT1 | |||
| In vitro: |
|
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.0207 mL | 20.1037 mL | 40.2075 mL | 80.4149 mL | 100.5187 mL |
| 5 mM | 0.8041 mL | 4.0207 mL | 8.0415 mL | 16.083 mL | 20.1037 mL |
| 10 mM | 0.4021 mL | 2.0104 mL | 4.0207 mL | 8.0415 mL | 10.0519 mL |
| 50 mM | 0.0804 mL | 0.4021 mL | 0.8041 mL | 1.6083 mL | 2.0104 mL |
| 100 mM | 0.0402 mL | 0.201 mL | 0.4021 mL | 0.8041 mL | 1.0052 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| Fimepinostat (CUDC-907); Fimepinostat (CUDC-907) | CFN60286 | 1339928-25-4 | C23H24N8O4S = 508.55 | 5mg | QQ客服:215959384 |
| Infigratinib (BGJ398); Infigratinib (BGJ398) | CFN60052 | 872511-34-7 | C26H31Cl2N7O3 = 560.48 | 5mg | QQ客服:2159513211 |
| bis[6-(5,6-dihydrochelerythrinyl)]amine; bis[6-(5,6-dihydrochelerythrinyl)]amine | CFN91015 | 165393-48-6 | C42H37N3O8 = 711.76 | 5mg | QQ客服:2159513211 |
| 4-羟基-2-甲基苯甲酸; 4-Hydroxy-2-methoxybenzoic acid | CFN95872 | 90111-34-5 | C8H8O4 = 168.2 | 10mg | QQ客服:215959384 |